Creo Medical Group (CREO)

Sector:

Health Care

Index:

FTSE AIM All-Share

16.13p
   
  • Change Today:
    -0.13p
  • 52 Week High: 48.10
  • 52 Week Low: 15.70
  • Currency: UK Pounds
  • Shares Issued: 412.15m
  • Volume: 519,832
  • Market Cap: £66.46m
  • Beta: 0.20

Creo Medical acquires Aber Electronics for undisclosed sum

By Iain Gilbert

Date: Friday 12 Nov 2021

LONDON (ShareCast) - (Sharecast News) - Medical device company Creo Medical Group has acquired power amplifier and radio frequency products manufacturer and designer Aber Electronics for an undisclosed, fixed cash consideration, plus a contingent consideration over a three-year period.

Creo, an existing customer of Aber, said the acquisition would complement its research, design and manufacturing processes, provide additional specialist microwave and radio frequency capability and expertise within the business and enhance a key element of the group's supply chain.

The AIM-listed firm anticipates leveraging the additional resource and expertise that it acquires via the addition of Aber to further develop its Kamaptive Technology, the advanced energy which powers its CROMA platform.

Chief executive Craig Gulliford said: "Being an existing customer of Aber and having worked closely with the management team for a number of years, we are familiar with the quality of its products and the team there, and I'd like to welcome them all to the Creo group.

"This acquisition fits with the 'buy' aspect of our three-tiered 'build, buy, partner' strategy, in acquiring a company with existing manufacturing operations, to complement and add capability in Creo's product development and production."

As of 0935 GMT, Creo Medical shares were up 0.97% at 156.50p.

Email this article to a friend

or share it with one of these popular networks:


Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

CREO Market Data

Currency UK Pounds
Share Price 16.13p
Change Today -0.13p
% Change -0.77 %
52 Week High 48.10
52 Week Low 15.70
Volume 519,832
Shares Issued 412.15m
Market Cap £66.46m
Beta 0.20

CREO Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
10.11% above the market average10.11% above the market average10.11% above the market average10.11% above the market average10.11% above the market average
20% below the sector average20% below the sector average20% below the sector average20% below the sector average20% below the sector average
Price Trend
84.58% below the market average84.58% below the market average84.58% below the market average84.58% below the market average84.58% below the market average
51.35% below the sector average51.35% below the sector average51.35% below the sector average51.35% below the sector average51.35% below the sector average
Income Not Available
Growth
24.32% above the market average24.32% above the market average24.32% above the market average24.32% above the market average24.32% above the market average
55.56% above the sector average55.56% above the sector average55.56% above the sector average55.56% above the sector average55.56% above the sector average

What The Brokers Say

Strong Buy 1
Buy 0
Neutral 0
Sell 0
Strong Sell 0
Total 1
strong_buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

CREO Dividends

No dividends found

Trades for 21-Nov-2024

Time Volume / Share Price
16:20 20,343 @ 16.12p
16:10 3,206 @ 16.15p
14:56 234 @ 16.24p
14:45 19,868 @ 16.12p
13:59 38,584 @ 16.12p

CREO Key Personnel

CEO Craig Jonathan Gulliford
CFO Richard John Rees

Top of Page